What Is CBDP? A Careful Cannabinoid Guide

Modified on: 29/05/2026

What CBDP means in a cannabinoid glossary

CBDP is one of the minor cannabinoids that occasionally appear in the long acronym list that follows a hemp lot through the laboratory. It sits next to better-known names like CBD, CBG, CBN and THCV, but most readers meet it for the first time on a chromatographic strip rather than on a product page. This Justbob guide explains what CBDP refers to, how it was first isolated, and how the acronym can show up in the documents that travel with a CBD product.

The goal is glossary-level clarity. After reading these sections, a CBDP mention in a lab report should be legible at a glance, and the reader should know what the acronym does and does not describe.

CBDP at a glance: the acronym and what it covers

CBDP stands for cannabidiphorol, a hemp-derived cannabinoid in the same family as cannabidiol (CBD). The “P” comes from the Greek root “phorol”, which signals a longer side chain on the molecule. Where CBD carries a five-carbon (pentyl) side chain, CBDP carries a seven-carbon (heptyl) side chain on the same core structure.

A reader meeting the acronym on a CBD hash certificate or on a flower lab report can think of it as a structural variant of CBD. The molecule shares the same basic backbone; the side chain is what changes the listing on the report.

Where CBDP sits in the hemp cannabinoid family

The cannabinoid family in industrial hemp counts more than 120 molecules, most of them present in trace amounts. The most cited members of the family are CBD, THC, CBG, CBN, CBC and CBDA, which usually appear on the cannabinoid breakdown of a certificate. CBDP belongs to the second tier, alongside acronyms like CBDV, CBL, CBT and THCP, that show up only when the laboratory protocol is detailed enough to detect them.

Reading these cannabinoids as a single chemical family is useful. They share the same biosynthetic origin from cannabigerolic acid (CBGA), and they differ from each other through small structural changes: the side chain length, the saturation pattern, or the cyclisation step that closes the ring system. CBDP is the heptyl-side-chain version of CBD, in the same way that THCP is the heptyl-side-chain version of THC.

How CBDP was first isolated and characterised

CBDP entered the scientific literature in late 2019. A research group led by Cinzia Citti and Giuseppe Cannazza, working between the University of Modena and Reggio Emilia, the Council for Agricultural Research and Economics (CREA-CIN) and Sapienza University of Rome, reported the isolation of two new phytocannabinoids from a research-grade Cannabis sativa variety: a heptyl analogue of THC (named THCP) and the corresponding heptyl analogue of CBD (named CBDP). The paper was published in Scientific Reports, a journal of the Nature group, on 30 December 2019.

The team used high-resolution liquid chromatography combined with mass spectrometry to separate the heptyl analogues from the rest of the cannabinoid fraction. The work added two molecules to the public catalogue of identified phytocannabinoids and put the heptyl side chain firmly on the map of hemp chemistry.

For a glossary reader, the date matters. CBDP is a relatively new entry: it does not appear on older textbooks, and many older laboratories do not yet include it in the standard cannabinoid panel that supports a certificate of analysis.

The CBDP acronym next to its more famous siblings

Placing CBDP next to its older siblings helps fix the acronym in mind. CBD (cannabidiol) is the headline cannabinoid for industrial hemp and the central reference on most catalog pages. CBG (cannabigerol) is the metabolic precursor of CBD, often present in trace amounts. CBN (cannabinol) is a degradation product of THC that builds up with time and exposure. CBC (cannabichromene) shares the same biosynthetic family.

CBDP fits into this list as a structural variant of CBD with a longer side chain. The acronym is not a marketing label or a sub-type sold separately; it is a molecule name, and it appears on a lab document when the analytical method is fine-grained enough to detect heptyl-side-chain cannabinoids.

A useful glossary cross-reference here is CBD vs THC: The Clear Difference In Product Language, which sits beside this article for readers who want a refresh on the two main cannabinoid acronyms before diving into the minor ones.

Why CBDP rarely appears on a product label

CBDP is present at trace levels in hemp varieties registered in the EU industrial hemp catalogue. The 2019 isolation work measured CBDP in parts per million order ranges, far below the percentages reported for CBD on a standard certificate. That low natural abundance is one of the main reasons CBDP rarely appears on the front of a product label: the molecule sits in the cannabinoid background, not in the headline numbers that frame the listing.

Read also: CBD Flower Lab Testing: What the Checks Show

A second reason is the analytical method. Detecting heptyl-side-chain cannabinoids requires a sensitive liquid-chromatography setup with mass-spectrometry coupling. A routine certificate of analysis often stops at the main panel (CBD, THC, CBG, CBN, CBC, and a few acids), and a CBDP line only appears when the laboratory was asked to extend the panel to the minor cannabinoid set.

How CBDP relates to THCP in the same discovery

THCP travels next to CBDP in the 2019 Citti paper. The two molecules share the same heptyl side chain on the cannabinoid backbone, with the only difference between them sitting in the ring system: the THC side has a tetrahydrocannabinol structure, the CBD side has a cannabidiol structure. The paper reported the two molecules together as a pair, and a reader meeting one acronym on a document will often find the other one a few lines away.

For glossary purposes, CBDP and THCP are best read as siblings. They were identified in the same body of work; they were named in the same paper; and they sit on the same heptyl branch of the phytocannabinoid family tree. The conversation around the two molecules has stayed mostly inside the scientific literature, with limited commercial product impact so far.

What a CBDP entry on a certificate of analysis can look like

A certificate of analysis that includes CBDP will usually list it under the minor cannabinoid section of the report, with a value expressed in percent or in parts per million depending on the laboratory convention. The acronym appears in a single column row, next to a numeric reading and, in some certificates, a limit-of-quantification flag when the value sits close to the detection threshold.

Read also: CBD Flower Appearance: What You Can Really See

Some certificates report CBDP as “n.d.” (not detected) or “below LOQ” (below limit of quantification). Both notations mean the laboratory looked for the molecule and did not find it at a quantifiable level. The line is still useful, because it signals that the heptyl analogue was on the testing panel.

Reading a cannabinoid acronym list with care

A cannabinoid acronym list is a long line of three or four letter codes followed by numerical values. Reading it with care means resisting the urge to skip to the headline figures. The minor cannabinoids carry the secondary chemistry of the lot, and acronyms like CBDP, THCP, CBDV and CBT add nuance to the cannabinoid fingerprint, even when their values are small.

Our reading is that the minor cannabinoid section is the part of the report that distinguishes one EU registered variety from another at the molecular level. Two lots can show similar CBD percentages and very different minor cannabinoid lines, and that difference is what gives the lot its specific chemical identity on the certificate.

Where Justbob documents CBDP and other cannabinoid presence

Justbob carries out constant analyses on all commercialised products and on every batch. The relevant documents are available inside each commercialised product page, so a reader who wants to confirm the cannabinoid breakdown, the THC threshold compliance or the presence of minor cannabinoids (where the laboratory panel reports them) for a specific lot can open the certificate of analysis without leaving the catalog.

The minor cannabinoid panel is not part of every certificate, because the analytical depth depends on the laboratory protocol selected for the lot. The catalog page makes the reference document available; the document itself shows whether the panel was extended to include heptyl-side-chain cannabinoids like CBDP.

That setup keeps the lot-specific story open to the reader. A CBDP line on the document is informative when present; its absence on a basic panel is not a sign of compliance issues, it is a sign of analytical depth.

Compliance-safe wording for a cannabinoid glossary topic

Compliance-safe wording for a CBDP glossary page stays strictly descriptive. “CBDP, a heptyl-side-chain analogue of CBD, identified in 2019 by Citti et al. and reported at trace levels on extended cannabinoid panels” describes the molecule. “CBDP, the next-generation cannabinoid you cannot miss” describes the marketer. The first earns the reader’s attention; the second sets off the signals that brought the page under review.

Hemp products are sold for technical, scientific and ornamental purposes only, in line with the EU industrial hemp framework. A cannabinoid acronym like CBDP belongs to the chemical vocabulary that supports the lot reading. It is not a directive, not a benefit and not an alternative to other regulated product categories.

The test is simple. If the CBDP entry helps you read the document, the page is using the acronym as glossary vocabulary. If the entry invites you to do something with the product, the page has stepped outside the safe lane.

Closing a CBDP read with the document in hand

A CBDP read is a quick discipline. Find the acronym in the minor cannabinoid section of the certificate; check whether the value is a number, a “n.d.” or a “below LOQ”; place CBDP next to the more familiar CBD reading at the top of the document; cross-reference the laboratory method to see whether the heptyl-side-chain panel was included; close the document with the EU registered variety in mind. The routine takes about a minute once the cannabinoid acronym set is familiar.

For scientific context, the PubMed Central paper on the discovery of CBDP and THCP is the primary source. It reports the 2019 isolation work in full, with the chromatography traces and the mass-spectrometry signatures that defined the two heptyl-side-chain cannabinoids, and it provides the reference frame for the acronym and the lab document reading explained in the sections above.

Frequently asked questions about what is cbdp

What does the acronym CBDP stand for?

CBDP stands for cannabidiphorol, a heptyl-side-chain analogue of cannabidiol (CBD). The “P” in the acronym signals the longer seven-carbon side chain on the molecule, where standard CBD carries a five-carbon pentyl side chain on the same core structure.

When was CBDP discovered?

CBDP was first isolated and characterised by a research group led by Cinzia Citti and Giuseppe Cannazza, working between the University of Modena and Reggio Emilia, CREA-CIN and Sapienza University of Rome. The result was published in Scientific Reports (Nature group) on 30 December 2019, alongside the related cannabinoid THCP.

Why does CBDP rarely appear on a product label?

CBDP sits in the minor cannabinoid section of a hemp variety, usually at parts-per-million order levels rather than at the percentages reported for CBD. Detecting it also requires a sensitive liquid-chromatography and mass-spectrometry method, so it appears on a certificate only when the laboratory protocol extends to the minor cannabinoid panel.